Cancer treatment has evolved significantly with the introduction of targeted therapies, offering patients more precise and effective treatment options. Sunitinib Malate Capsules are among the most trusted targeted anti-cancer medicines used worldwide for treating several advanced cancers.
Cordium Pharmaceuticals Pvt Ltd, a leading Indian pharmaceutical exporter, supplies high-quality Sunitinib Malate Capsules to international markets, ensuring affordable access to life-saving oncology medications.
What are Sunitinib Malate Capsules?
Sunitinib Malate is an oral targeted therapy medication classified as a tyrosine kinase inhibitor (TKI). It works by blocking specific proteins that help cancer cells grow and develop blood vessels.
This medicine slows down or stops the progression of cancer and is widely prescribed by oncologists globally.
What Conditions are Treated with Sunitinib Malate Capsules?
1. Advanced Renal Cell Carcinoma (Kidney Cancer)
Sunitinib is commonly used as a first-line treatment for advanced kidney cancer by inhibiting tumor growth and reducing blood supply to cancer cells.
Kidney cancer treatment
Advanced renal cell carcinoma medicine
Targeted therapy for kidney cancer
Affordable kidney cancer treatment
2. Gastrointestinal Stromal Tumors (GIST)
Sunitinib is prescribed for patients with GIST when other treatments are ineffective or unsuitable.
3. Pancreatic Neuroendocrine Tumors (pNET)
Sunitinib helps manage advanced pancreatic neuroendocrine tumors by slowing tumor progression.
How Does Sunitinib Malate Work?
Sunitinib blocks multiple receptors involved in cancer growth, including:
VEGFR (Vascular Endothelial Growth Factor Receptor)
PDGFR (Platelet-Derived Growth Factor Receptor)
KIT receptor
FLT3 receptor
By blocking these pathways, Sunitinib:
✅ Slows cancer cell growth
✅ Prevents formation of new blood vessels
✅ Reduces tumor progression
✅ Improves disease control
Benefits of Sunitinib Malate Capsules
Why Oncologists Prefer Sunitinib
Oral capsule administration
Proven effectiveness in multiple cancers
Long-term disease management
Reduced tumor progression
Globally recognized targeted therapy
Suitable for outpatient treatment
Common Side Effects of Sunitinib Malate
Patients may experience:
Fatigue
High blood pressure
Diarrhea
Nausea
Loss of appetite
Mouth sores
Skin discoloration
Hand-foot syndrome
Low platelet count
Important: Treatment should always be monitored by a qualified oncologist.
Global Demand for Sunitinib Malate Capsules
Demand for affordable targeted oncology medicines is increasing across:
Kenya
Nigeria
Ghana
Philippines
Vietnam
United Arab Emirates
Saudi Arabia
Uzbekistan
Kazakhstan
United States
United Kingdom
South Africa
Healthcare providers and pharmaceutical distributors are actively seeking reliable oncology suppliers to improve access to life-saving medicines.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is committed to supplying premium-quality oncology medicines worldwide.
Our Advantages
✔ WHO-GMP quality standards
✔ Reliable global exports
✔ Competitive pricing
✔ Regulatory documentation support
✔ Timely international delivery
✔ Dedicated customer support
✔ Bulk supply capabilities
